SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-013878
Filing Date
2021-03-17
Accepted
2021-03-17 16:31:03
Documents
14
Period of Report
2021-03-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR NEW DIRECTORS adpt-8k_20210316.htm   iXBRL 8-K 45257
2 EX-99.1 adpt-ex991_24.htm EX-99.1 12600
3 GRAPHIC g41htwh3dpjv000001.jpg GRAPHIC 14224
  Complete submission text file 0001564590-21-013878.txt   213494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adpt-20210316.xsd EX-101.SCH 5804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20210316_lab.xml EX-101.LAB 19480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20210316_pre.xml EX-101.PRE 11653
7 EXTRACTED XBRL INSTANCE DOCUMENT adpt-8k_20210316_htm.xml XML 3577
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 21750970
SIC: 2836 Biological Products, (No Diagnostic Substances)